News Releases

March 30, 2021
DURHAM, N.C., March 30, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc . (“Bioness”), a global leader in neuromodulation and rehabilitation medical devices through its innovative
March 4, 2021
DURHAM, N.C., March 04, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”) , a global leader in innovations for active healing, has appointed Larry Chen as Managing Director, China and Asia Pacific. Chen has more than 20 years of experience in sales and marketing
February 10, 2021
DURHAM, N.C., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. ("Bioventus" or the “Company”) today announced the pricing of its initial public offering of 8,000,000 shares of Class A common stock at a public offering price of $13.00 per share. The Company’s Class A common stock is expected to
February 4, 2021
DURHAM, N.C. --(BUSINESS WIRE)--Feb. 4, 2021-- Bioventus Inc. (" Bioventus " or the “Company”), today announced that it has commenced the initial public offering of its Class A common stock. Bioventus is offering 7,350,000 shares of its Class A common stock.
Displaying 1 - 10 of 44